Literature DB >> 8740735

The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants.

L J Herrinton1, M Goldoft, S M Schwartz, N S Weiss.   

Abstract

We examined the incidence of non-Hodgkin's lymphoma (NHL) in Chinese, Japanese, and Filipino residents of the United States to obtain further clues about the etiology of the disease. The age, race, and birthplace of residents of Hawaii, San Francisco/Oakland (California), and western Washington who had received a diagnosis of NHL during the period 1973-86 were obtained from population-based cancer registries, and a special tabulation from the 1980 Census was used to estimate the number of person-years at risk for each category of resident. The incidence of NHL in each of the Asian groups examined was 35 to 85 percent that of US-born Whites. However, there was no consistent trend of increasing incidence with increasing generation of residence in any of the groups. In Asian-Americans, the risk of small cell lymphocytic and plasmacytoid lymphoma was 10 to 85 percent that of Whites, although no clear trends of risk with generation of residence in the US were observed. They also were at a reduced risk of follicular lymphoma, and in Chinese and Japanese persons, the risk was lower in first generation than in later generation migrants (Chinese: Asian-born relative risk [RR] = 0.11, US-born, RR = 0.84; Japanese: Asian-born, RR = 0.15, US-born, RR = 0.36). The risk of diffuse lymphoma was similar in Chinese- and Japanese-Americans and US-born Whites. We conclude that, with the exception of follicular lymphoma, the basis for the relatively low incidence of NHL in Asian-Americans does not lie in exposures or characteristics that differ between the migrants themselves and their descendants.

Entities:  

Mesh:

Year:  1996        PMID: 8740735     DOI: 10.1007/bf00051298

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  16 in total

1.  The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Research directions and general discussion: a summary.

Authors:  N E Mueller; J F Fraumeni
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

2.  Use of the working formulation for non-Hodgkin's lymphoma in epidemiologic studies: agreement between reported diagnoses and a panel of experienced pathologists.

Authors:  F Dick; S VanLier; P Banks; G Frizzera; G Witrak; R Gibson; G Everett; L Schuman; P Isacson; G O'Conor
Journal:  J Natl Cancer Inst       Date:  1987-06       Impact factor: 13.506

3.  Agreement rates and American-Japanese pathologists' comparability of a modified Working Formulation for non-Hodgkin's lymphomas. An analysis of the cases collected for the Fifth International Workshop on Chromosomes in Leukemia-Lymphoma.

Authors:  K Nanba; H Yamamoto; N Kamada; M Kikuchi; T Suchi; G Frizzera; C W Berard; K Shimamura; Y Kaneko; M Sakurai
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

4.  Comparability of marital status, race, nativity, and country of origin on the death certificate and matching census record.

Authors:  T Z Hambright
Journal:  Vital Health Stat 2       Date:  1969-05

5.  Time trends in Hodgkin's disease incidence. The role of diagnostic accuracy.

Authors:  S L Glaser; W G Swartz
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

6.  Direct standardization of incidence rates in the presence of incomplete data.

Authors:  S S Emerson; J C Emerson
Journal:  Stat Med       Date:  1993-01-15       Impact factor: 2.373

7.  Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception.

Authors:  H Kim; R J Zelman; M A Fox; J M Bennett; C W Berard; J J Butler; G E Byrne; R F Dorfman; R J Hartsock; R J Lukes; R B Mann; R S Neiman; J W Rebuck; W W Sheehan; D Variakojis; J F Wilson; H Rappaport
Journal:  J Natl Cancer Inst       Date:  1982-01       Impact factor: 13.506

8.  Non-Hodgkin's lymphomas. Application of the International Classification of Diseases for Oncology (ICD-O) to the Working Formulation.

Authors:  C Percy; G O'Conor; L G Ries; E S Jaffe
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

9.  Antigenic stimulation and the occurrence of multiple myeloma.

Authors:  T D Koepsell; J R Daling; N S Weiss; J W Taylor; A F Olshan; J L Lyon; G M Swanson; M Child
Journal:  Am J Epidemiol       Date:  1987-12       Impact factor: 4.897

10.  Ovarian cancer incidence among Asian migrants to the United States and their descendants.

Authors:  L J Herrinton; J L Stanford; S M Schwartz; N S Weiss
Journal:  J Natl Cancer Inst       Date:  1994-09-07       Impact factor: 13.506

View more
  14 in total

1.  Follicular lymphoma in Osaka, Japan: histological features and chronological change.

Authors:  Hajime Miyazato; Shin-ichi Nakatsuka; Itsuko Miyanaga; Hitoshi Hanamoto; Yoichi Tatsumi; Mitsuhiro Matsuda; Yasuhiro Maeda; Akihisa Kanamaru; Katsuyuki Aozasa
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Studying cancer incidence and outcomes in immigrants: methodological concerns.

Authors:  Scarlett S Lin; Christina A Clarke; Cynthia D O'Malley; Gem M Le
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

3.  Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong.

Authors:  Qing Lan; Wing-Yan Au; Stephen Chanock; Jovic Tse; Kit-fai Wong; Min Shen; L P Siu; Jeff Yuenger; Meredith Yeager; Howard Dean Hosgood; Mark P Purdue; Raymond Liang; Nathaniel Rothman
Journal:  Eur J Haematol       Date:  2010-12       Impact factor: 2.997

4.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

5.  Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation.

Authors:  Christina A Clarke; Sally L Glaser; Scarlett L Gomez; Sophia S Wang; Theresa H Keegan; Juan Yang; Ellen T Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-14       Impact factor: 4.254

6.  Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.

Authors:  Anamarija M Perry; Jacques Diebold; Bharat N Nathwani; Kenneth A MacLennan; Hans K Müller-Hermelink; Martin Bast; Eugene Boilesen; James O Armitage; Dennis D Weisenburger
Journal:  Haematologica       Date:  2016-06-27       Impact factor: 9.941

7.  Uncovering nativity disparities in cancer patterns: Multiple imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results data file.

Authors:  Jane R Montealegre; Renke Zhou; E Susan Amirian; Michael E Scheurer
Journal:  Cancer       Date:  2014-01-16       Impact factor: 6.860

8.  Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada.

Authors:  M Le; F M Ghazawi; A Alakel; E Netchiporouk; E Rahme; A Zubarev; M Powell; L Moreau; O Roshdy; S J Glassman; D Sasseville; G Popradi; I V Litvinov
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

Review 9.  Economic burden of follicular non-Hodgkin's lymphoma.

Authors:  Talia Foster; Jeffrey D Miller; Mark E Boye; Mason W Russell
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Exploring risk factors for follicular lymphoma.

Authors:  Alexander J Ambinder; Pareen J Shenoy; Neha Malik; Alison Maggioncalda; Loretta J Nastoupil; Christopher R Flowers
Journal:  Adv Hematol       Date:  2012-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.